Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus +/- Cetuximab in Recurrent/Metastatic HNSCC
NCT01256385Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of temsirolimus in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Nov 2010; status: completed.
02
Drugs
temsirolimus
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01256385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01256385.